An example of the application of Mössbauer spectroscopy for determination of concentration of iron in lyophilized brain tissue

Open access


Mössbauer spectroscopy is not routinely used for the determination of the concentration of iron. However, as this method does not need any pre-treatment of samples before measurements, it may be of extreme importance for the assessment of iron in samples, which can then be used for further investigations. Biological samples are a good example, however, as the concentrations of iron are very low in these, it is important to exclude possible artefacts from the background spectrum related to iron present in the counter and cryostat windows. The aim of this study was to compare two methods of determination of the amounts of iron in investigated sample: one, in which the background spectrum was subtracted from the sample spectrum measured, and the other, in which the obtained non-elaborated spectrum was fitted with two doublets - a doublet for the measured sample and a doublet for the background spectrum. Three samples containing known amounts of natural iron (400, 800 and 1600 μg) and a sample of lyophilized human brain tissue obtained from globus pallidus were assessed. Both methods led to the creation of a very good calibration curve with a correlation coefficient of 0.99. Although both methods gave similar results for the concentration of iron in the sample, the subtraction of the background spectrum had a significantly lower error of the final result.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Herr W. & Skerra B. (1969). Mössbauer spectroscopy applied to the classifi cation of stone meteorites. In: P. M. Millman (Ed.) Meteorite research (Vol. 12 pp. 106-122). Astrophysics and Space Series. Science Library. Dordrecht: D. Reidel Pub. Co.

  • 2. Morris R. V. Klingelhöfer G. Korotev L. R. & Shelfer T. D. (1998). Mössbauer mineralogy on the Moon: The lunar regolith. Hyperfi ne Interact. 117 405-432.

  • 3. Bauminger E. R. Barcikowska M. Friedman A. Hechel D. & Nowik I. (1994). Does iron play a role in Parkinson’s disease? Hyperfi ne Interact. 91 853-856.

  • 4. Dubiel S. M. Zabłotna-Rypień B. Mackey J. B. & Williams J. M. (1999). Magnetic properties of human liver and brain ferritin. Eur. Biophys. J. 28 263-267.

  • 5. Gerlach M. Trautwein A. X. Zecca L. Youdim M. B. H. & Riederer P. (1995). Mössbauer spectroscopic studies of purifi ed human neuromelanin isolated from the substantia nigra. J. Neurochem. 65 923-926.

  • 6. Galazka-Friedman J. Bauminger E. R. Koziorowski D. & Friedman A. (2004). Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson’s disease and control substantia nigra. Biochim. Biophys. Acta 1688 130-136.

  • 7. Zecca L. Gallorini M. Schunemann V. Trautwein A. X. Gerlach M. Riederer P. Vezzoni P. & Tampellini D. (2001). Iron neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J. Neurochem. 76(6) 1766-1773.

  • 8. Miglierini M. Rocca R. Kopani M. & Lancok A. (2014). Mössbauer and SQUID characterization of iron in human tissue: case of globus pallidus. Acta Phys. Pol. A 126 240-241.

Journal information
Impact Factor

IMPACT FACTOR 2018: 0.585
5-year IMPACT FACTOR: 0.513

CiteScore 2018: 0.60

SCImago Journal Rank (SJR) 2018: 0.250
Source Normalized Impact per Paper (SNIP) 2018: 0.527

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 219 126 2
PDF Downloads 201 148 14